Acquisition Opportunity Bio-Optronics was acquired by Advarra in January 2021, creating a pathway for cross-sell and integration with Advarra’s regulatory review solutions. The CTMS and CCTrialSuite products can be offered to Advarra customers seeking end-to-end eClinical workflows.

Mid-market Focus With a lean team and a solid revenue footprint, Bio-Optronics targets mid-market healthcare and research sites that require scalable CTMS, scheduling, and patient identification capabilities. The product suite serves hospitals, imaging centers, and long-term care facilities seeking integrated operational software.

Remote Trial Strength The company has demonstrated emphasis on remote monitoring and telehealth through CCeConsent enhancements and guidance for Optimize Your Site Visits with Remote Monitoring, supporting sales into organizations expanding virtual trials and remote oversight.

Product Suite Power Core offerings include Clinical Conductor CTMS, Momentum scheduling, and Biopoint patient identification, delivering end-to-end trial management and clinical operations. A single vendor solution can reduce integration risk for customers moving from disparate systems.

Growth Credibility Recognized as a fastest-growing Rochester company and backed by a long history of healthcare partnerships, Bio-Optronics brings credibility to the sales process. The Advarra acquisition further enhances market relevance and potential access to larger enterprise customers.